Efficacy and safety of ponatinib in patients with CP-CML who failed second-generation TKIs Presented ByDr Hagop Kantarjian, MD Anderson Cancer Center, Texas, USA TrialOPTIC, PACE ConferenceASH 2020 18 February, 2021 09:08